Miragen Therapeutics shares owned by Carmichael Hill & Associates
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Carmichael Hill & Associates
from 13F filings
Historical chart of Carmichael Hill & Associates investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Carmichael Hill & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Carmichael Hill & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $701 | 40 | 17.53 |
| 2023-12-31 | $872 | 40 | 21.80 |
| 2023-09-30 | $614 | 40 | 15.35 |
| 2023-06-30 | $952 | 40 | 23.80 |
| 2023-03-31 | $1.0k | 40 | 25.45 |
| 2022-12-31 | $1.2k | 40 | 29.20 |
| 2022-09-30 | $1.0k | 40 | 25.00 |
| 2022-06-30 | $0 | 40 | 0.00 |
More positions owned by Carmichael Hill & Associates
View all positions for Carmichael Hill & Associates